FDA Drug Recalls

Recalls / Class II

Class IID-0507-2023

Product

Alprazolam C-IV, 0.5 mg, 30 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-0240-30.

Affected lot / code info
Lot: 11AP2219 Exp. 4/30/23

Why it was recalled

CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.

Recalling firm

Firm
Direct Rx
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
94 Worldwide Dr, Dawsonville, Georgia 30534-6828

Distribution

Quantity
20 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2023-03-22
FDA classified
2023-04-06
Posted by FDA
2023-04-12
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0507-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls